51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ITMCTR2100005418	2019-10-01	2021-12-17	Observation of clinical efficacy of Ying-Pi No.1 hand mask cream in the treatment of scleroderma	Observation of clinical efficacy of Ying-Pi No.1 hand mask cream in the treatment of scleroderma	scleroderma	Test group:MTX+ Alprostadilinjection + Guipiperate maleate injection + Ying-Pi No.1 hand mask cream ...	The First Affiliated Hospital of Zhejiang Chinese Medicine University	NULL	Completed	28	78	Both	Test group:30;Control group:30;		China
2	ChiCTR2100054434	2019-10-01	2021-12-17	Observation of clinical efficacy of Ying-Pi No.1 hand mask cream in the treatment of scleroderma	Observation of clinical efficacy of Ying-Pi No.1 hand mask cream in the treatment of scleroderma	scleroderma	Experimental group:MTX+ Alprostadilinjection + Guipiperate maleate injection + Ying-Pi No.1 hand mas ...	The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine	NULL	Completed	28	78	Both	Experimental group:30;Control group:30;		China
3	NCT02228850 (ClinicalTrials.gov)	November 2014	20/8/2014	Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Pheno ...	A Phase 2a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of the Acute Peripheral Vasc ...	Raynaud's Phenomenon Secondary to Systemic Sclerosis	Drug: Alprostadil;Other: Placebo	NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)	NULL	Completed	18 Years	79 Years	Both	35	Phase 2	United States

First Previous1Next Last